EP2632546B1 - Planungssystem für eine nervenstimulationstherapie - Google Patents
Planungssystem für eine nervenstimulationstherapie Download PDFInfo
- Publication number
- EP2632546B1 EP2632546B1 EP11776793.9A EP11776793A EP2632546B1 EP 2632546 B1 EP2632546 B1 EP 2632546B1 EP 11776793 A EP11776793 A EP 11776793A EP 2632546 B1 EP2632546 B1 EP 2632546B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- orientation
- fiber bundle
- probe
- stimulation
- implantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002560 therapeutic procedure Methods 0.000 title description 6
- 239000000835 fiber Substances 0.000 claims description 80
- 239000000523 sample Substances 0.000 claims description 80
- 230000000638 stimulation Effects 0.000 claims description 64
- 238000002513 implantation Methods 0.000 claims description 32
- 230000001225 therapeutic effect Effects 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 238000005457 optimization Methods 0.000 claims description 16
- 230000005684 electric field Effects 0.000 claims description 11
- 238000004590 computer program Methods 0.000 claims description 8
- 238000009826 distribution Methods 0.000 claims description 6
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 3
- 238000003384 imaging method Methods 0.000 description 8
- 230000002411 adverse Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 230000004913 activation Effects 0.000 description 3
- 238000003491 array Methods 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002598 diffusion tensor imaging Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000011351 state-of-the-art imaging technique Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37235—Aspects of the external programmer
- A61N1/37247—User interfaces, e.g. input or presentation means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/08—Arrangements or circuits for monitoring, protecting, controlling or indicating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
Definitions
- This invention relates to a system for planning implantation of a neurostimulation probe, the system comprising an input for receiving anatomical data comprising information regarding a position of at least one fiber bundle in a target region, an input for receiving therapeutic information comprising information regarding a stimulation preferability of the at least one fiber bundle, an optimization module for based on the position and the stimulation preferability of the at least one fiber bundle calculating an optimal position for implantation of the neurostimulation probe at which the probe is positioned to enable stimulation of at least one fiber bundle with a high stimulation preferability and an output for providing the optimal position.
- This invention further relates to a method and a computer program product for planning implantation of a neurostimulation probe.
- Systems for providing neurostimulation via an implanted probe are used for treatment of disorders such as chronic pain, Parkinson's disease, tremor and dystonia.
- Neurostimulation is used for stimulating neural tissue in the brain, the spinal cord and peripheral nerves.
- neurostimulation of brain tissue will be discussed.
- the system and method according to the invention can also be used for neurostimulation of, e.g., the spinal cord and peripheral nerves.
- the probe is surgically implanted in the brain, close to the brain tissue that is to be stimulated. When using neurostimulation it is important to stimulate the tissue that needs stimulation and to avoid stimulation of other nearby tissue. Correct placement of the probe thus is an important step in a successful neurostimulation treatment.
- imaging techniques such as Magnetic Resonance Imaging (MRI) are used to visualize the target region. The surgeon tries to locate the structures that need stimulation and tries to define a surgical plan to implant the probe in the identified structure.
- MRI Magnetic Resonance Imaging
- a known way of trying to stimulate the correct tissue region is to implant a probe with a plurality of electrodes and to select only a subset of these electrodes so as to stimulate only specific tissue regions. This is, e.g., described in US patent application US 2008/0215125 .
- This US application describes a probe with a plurality of electrodes which is implanted close to the region of interest. Electrical charges are supplied to a subset of these electrodes to selectively stimulate specific tissue regions.
- a subset of a plurality of electrodes is activated to steer an electrical field to the target region.
- the selective activation of a subset of the electrodes makes the precise probe location relative to the target structure less critical.
- WO 2004/096018 discloses a system for planning implantation of a neurostimulation probe comprising an input for receiving anatomical data comprising information regarding a target region, an input for receiving therapeutic information comprising information regarding a stimulation preferability of the at least one fiber bundle, an optimization module for calculating at least one optimal position and at least one optimal orientation for implantation of the neurostimulation probe and an output for providing the optimal position and orientation.
- this object is achieved by providing a system for planning implantation of a neurostimulation probe, the system comprising an input for receiving anatomical data comprising information regarding a position and an orientation of at least one fiber bundle in a target region, an input for receiving therapeutic information comprising information regarding a stimulation preferability of the at least one fiber bundle, an optimization module for based on the position, the orientation and the stimulation preferability of the at least one fiber bundle calculating at least one optimal position and at least one optimal orientation for implantation of the neurostimulation probe at which optimal position and orientation the probe is capable of generating an electric field gradient substantially parallel to at least one fiber bundle with a high stimulation preferability and/or substantially perpendicular to at least one fiber bundle with a low stimulation preferability and an output for providing the optimal position and orientation.
- the planning system according to the invention does not only take into account the position of the target structure but also its orientation for planning the implantation of the neurostimulation probe. Especially for fiber bundles, the orientation of the electric stimulation field relative to the orientation of the fiber bundle is an important factor determining the effectiveness of the neurostimulation therapy. While the prior art planning systems only try to stimulate the brain at specific target positions, the planning systems according to the invention also takes into account the direction of the target fibers and the direction of the gradients of the electric stimulation fields that can be generated by the neurostimulation probe. It is to be noted that the planning system according to the invention may also be used for planning the implantation of two or more probes. However, in the following we will assume that only one probe is to be implanted.
- the system according to the invention may comprise an imaging apparatus and may derive fiber bundle positions and orientations from images obtained by the imaging apparatus.
- the system may receive the image information regarding the fiber bundle positions and orientations from an external source or a brain atlas containing fiber orientations may be registered to anatomic images like MRI.
- the system also receives information regarding the stimulation preferability of one or more fiber bundles.
- the stimulation preferability may, e.g., be provided as a simple list of fiber bundles that need stimulation for obtaining a desired therapeutic effect. Also a list of fiber bundles that should not be stimulated in order to avoid adverse side effects may be provided.
- the stimulation preferability is preferably expressed as a value indicating a level of desirability for a certain fiber bundle to be stimulated.
- the stimulation preferability may be obtained by a user selecting one or more fibers that should (or should not) be stimulated.
- a pointing device such as a mouse or joystick may be used for highlighting important fiber bundles in a displayed image of the target region.
- the user may also be allowed to assign a level of stimulation preferability to the highlighted fiber bundles.
- the anatomical information may include information identifying the different fiber bundles and the therapeutic information may include information about what fiber bundles are to be stimulated: The system may then be arranged to select the fiber bundles that need stimulation.
- the optimization module uses the gathered information (anatomical information with positions and orientations of fiber bundles and therapeutic information indicating stimulation preferabilities) to determine an optimal position and orientation for implantation of the probe.
- the therapeutic effect of the stimulation may be maximized or the adverse side effects of the stimulation therapy may be minimized: In most cases the optimal position and orientation of the probe will provide a balance between maximizing expected positive effects and minimizing the expected adverse effects.
- the optimization module may also provide multiple optimal or close to optimal positions and orientations or a range of suitable positions and orientations.
- the optimization module may take into account the possible 3D electrical field distributions that can be generated by the plurality of electrodes. Due to constraints on the distribution of stimulation electrodes (e.g. the geometry of the probe, limitation on the number of probes that can safely be implanted) not all 3D configurations of stimulation fields can be constructed. For example for axially shaped probes with multiple cylindrical electrodes it is easier to control field gradients parallel to the axis of the probe than to control perpendicular field gradients. For probes carrying (2D) electrode arrays on a cylindrical carrier body more field configurations become available.
- the optimization module in the system according to the invention may solve such problems by comparing the possible 3D orientations for the stimulation field to the positions and orientations of fiber bundles that should (or should not) be stimulated.
- the planning system provides the optimal position and orientation for implantation of the probe.
- This information may, e.g., be provided by superimposing a graphical representation of the probe on an image of the target region.
- a method of planning implantation of a neurostimulation probe comprises the steps of receiving anatomical data and therapeutic data, calculating at least one optimal position and at least one optimal orientation for implantation of the probe and providing the optimal position and orientation.
- the anatomical data comprises information regarding a position and an orientation of at least one fiber bundle in a target region.
- the therapeutic information comprises information regarding a stimulation preferability of the at least one fiber bundle.
- the calculation of the optimal position and orientation for implantation of the probe is based on the position, the orientation and the stimulation preferability of the at least one fiber bundle in the target region.
- the probe is capable of generating an electric field gradient substantially parallel to at least one fiber bundle with a high stimulation preferability and/or substantially perpendicular to at least one fiber bundle with a low stimulation preferability.
- a computer program product for causing a processor to perform the above described method.
- FIG. 1 schematically shows a planning system 10 according to the invention.
- the planning system 10 may be embodied by a suitably programmed personal computer or by a dedicated medical system.
- the planning system 10 at least comprises an input 18 for receiving anatomical and therapeutic information and an optimization module for calculating the optimal position and orientation for implantation of the probe.
- the optimization module may be implemented in software, running on a processor 11.
- the system 10 preferably comprises, or is coupled to, a user interface for allowing the user to control the planning process.
- the user interface may comprise a keyboard and/or a pointing device, such as a mouse 14 for interacting with a graphical user interface displayed on a display 13.
- the display 13 is also coupled to the processor 11 via an output 19.
- a storage medium 12 is also coupled to the processor 11 and may, e.g., be used for storing program code, configuration data, medical information databases or patient data.
- the storage medium 12 may also comprise the anatomical data and therapeutic data that are needed for planning the implantation of the probe.
- the system 10 may comprise or be coupled to an imaging apparatus 15 for obtaining images of the target region. Those images may be used for determining a position and an orientation of at least one fiber bundle in the target region. Usually Diffuse Tensor Imaging (DTI) is used for visualizing fiber bundles, but other imaging techniques may also be suitable for the planning method according to the invention.
- the processor 11 may be configured to derive positions and orientations of fiber bundles from the images. If no imaging apparatus 15 is used, the system 10 may, e.g., receive at the input 18 a list or database with position and orientation data of fiber bundles in the target region. Below, with reference to figure 2 it is elucidated how the system 10 is used for calculating the optimal position and orientation for implantation of the probe.
- FIG. 2 shows a flow diagram of a method according to the invention.
- the method starts with input step 21.
- the system 10 receives anatomical information 30 and therapeutic information 40.
- the anatomical information 30 may be in the form of an image of fiber bundles 31 in a target region, or may just be data describing fiber bundle positions and orientations. If the anatomical information 30 is provided in the form of images, the fiber bundle positions and orientations may be determined by dedicated image recognition software.
- the anatomical information 30 may cover, e.g., a larger brain region, allowing a user to select a target region. Selecting the target region may, e.g., be done using the pointing device 14 to select part of a 2D or 3D graphical representation of the region for which anatomical information 30 is available.
- the therapeutic information 40 comprises information regarding the stimulation preferability of specific fiber bundles 31.
- the therapeutic information 40 may be symptom related and derived from, e.g., a database with medical information. Alternatively, it may be possible for a user to indicate which fiber bundles 31 should be stimulated and which ones not.
- the stimulation preferability may be a binary value indicating 'stimulation' or 'no stimulation', but may also be a continuous or discrete value on a scale ranging from 'stimulation highly preferable' to 'absolutely no stimulation'.
- the combined data 50 comprises a list or database with fiber bundles 31, with for each fiber bundle a position, an orientation and a stimulation preferability.
- fiber bundles 30 are not straight lines of uniform thickness.
- the input data preferably describes the full trajectory of a fiber bundle 30. Different parts of the fiber bundles 30 may have different orientations or shapes.
- the stimulation preferability of a fiber bundle 30 may also vary along the fiber bundle 30. The stimulation of the fiber bundle 30 may depend on the diameter of the fiber bundle 30.
- the combined data is visualized by highlighting a fiber bundle 32 that should be stimulated and a fiber bundle 33 for which stimulation is preferably avoided. Such a visualization may also be provided on a display 13 of the system 10.
- the combined data is used 50 for calculating an optimal position and orientation for one or more probes.
- the therapeutic effect of the stimulation may be maximized (probe 35 in figure 2 ) or the adverse side effects of the stimulation therapy may be minimized (probe 34 in figure 2 ).
- the optimal position and orientation of the probe will provide a balance between maximizing expected positive effects and minimizing the expected adverse effects. Since fiber bundles 31 may have different orientations at different positions, the optimal probe position may be close to a section of a fiber bundle 32 to be stimulated, which section is perpendicular to a nearby fiber bundle 33 which should not be stimulated.
- the probe For optimal stimulation of a target fiber 32, the probe is placed close to the bundle 32 to be stimulated. If the probe is closer to the fiber, the electrical stimulation field can be less strong and the chance of adverse effects caused by stimulation of nearby fiber bundles is reduced. Fiber bundles tend to be narrower at the center than close to the ends. When the probe is used to stimulate the fiber bundle where the diameter is relatively small, a less strong electrical stimulation field is required.
- the optimization step 22 may take into account the possible 3D electrical field distributions that can be generated after implantation. Due to constraints on the distribution of stimulation electrodes (e.g. the geometry of the probe, limitation on the number of probes that can safely be implanted) not all 3D configurations of stimulation fields can be constructed. The optimization step 22 may thus compare the possible 3D orientations for the stimulation field to the positions and orientations of fiber bundles that should (or should not) be stimulated.
- the optimal position and orientation may, e.g., be provided as a data file with information about the optimal position and orientation.
- a data file may be used as input in a system for monitoring the actual implantation of the probe or probes.
- the display 13 of the planning system 10 may show images of the target region complemented with a graphical representation of the probe to be implanted. Additionally, tolerance ranges may be shown for indicating how accurate the probe must be placed.
- the system is also configured to show an actual position of a real probe during implantation. This would allow a surgeon to compare the actual position and orientation of the probe to the calculated optimal probe position. This may, e.g., be realized by superimposing the calculated optimal position for the probe on real time images of the target region.
- the invention also extends to computer programs, particularly computer programs on or in a carrier, adapted for putting the invention into practice.
- the program may be in the form of source code, object code, a code intermediate source and object code such as partially compiled form, or in any other form suitable for use in the implementation of the method according to the invention.
- a program may have many different architectural designs.
- a program code implementing the functionality of the method or system according to the invention may be subdivided into one or more subroutines. Many different ways to distribute the functionality among these subroutines will be apparent to the skilled person.
- the subroutines may be stored together in one executable file to form a self-contained program.
- Such an executable file may comprise computer executable instructions, for example processor instructions and/or interpreter instructions (e.g. Java interpreter instructions).
- one or more or all of the subroutines may be stored in at least one external library file and linked with a main program either statically or dynamically, e.g. at run-time.
- the main program contains at least one call to at least one of the subroutines.
- the subroutines may comprise function calls to each other.
- An embodiment relating to a computer program product comprises computer executable instructions corresponding to each of the processing steps of at least one of the methods set forth. These instructions may be subdivided into subroutines and/or be stored in one or more files that may be linked statically or dynamically.
- Another embodiment relating to a computer program product comprises computer executable instructions corresponding to each of the means of at least one of the systems and/or products set forth. These instructions may be subdivided into subroutines and/or be stored in one or more files that may be linked statically or dynamically.
- the carrier of a computer program may be any entity or device capable of carrying the program.
- the carrier may include a storage medium, such as a ROM, for example a CD ROM or a semiconductor ROM, or a magnetic recording medium, for example a floppy disc or hard disk.
- the carrier may be a transmissible carrier such as an electrical or optical signal, which may be conveyed via electrical or optical cable or by radio or other means.
- the carrier may be constituted by such cable or other device or means.
- the carrier may be an integrated circuit in which the program is embedded, the integrated circuit being adapted for performing, or for use in the performance of, the relevant method.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Human Computer Interaction (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Electrotherapy Devices (AREA)
Claims (7)
- System (10) zur Planung der Implantation einer Neurostimulationssonde, wobei das System Folgendes umfasst:- einen Eingang (18) zum Empfangen anatomischer Daten, die Informationen bezüglich einer Position und einer Ausrichtung wenigstens eines Faserbündels in einer Zielregion umfassen,- einen Eingang (18) zum Empfangen therapeutischer Informationen, die Informationen bezüglich einer Stimulationsvorzugswürdigkeit des wenigstens einen Faserbündels umfassen,- ein Optimierungsmodul zur Berechnung wenigstens einer optimalen Position und wenigstens einer optimalen Ausrichtung zur Implantation der Neurostimulationssonde anhand der Position, der Ausrichtung und der Stimulationsvorzugswürdigkeit des wenigstens einen Faserbündels, wobei die Sonde in der optimalen Position und mit der optimalen Ausrichtung zur Erzeugung eines Gradienten eines elektrischen Feldes in der Lage ist, der im Wesentlichen parallel zu wenigstens einem Faserbündel mit einer hohen Stimulationsvorzugswürdigkeit und/oder im Wesentlichen senkrecht zu wenigstens einem Faserbündel mit einer geringen Stimulationsvorzugswürdigkeit ist, und- einen Ausgang zur Lieferung der optimalen Position und Ausrichtung.
- System zur Planung der Implantation einer Neurostimulationssonde nach Anspruch 1, bei dem die Neurostimulationssonde eine Anordnung von Stimulationselektroden umfasst und das Optimierungsmodul eine Reihe dreidimensionaler Verteilungen des elektrischen Feldes berücksichtigt, die von der Anordnung von Stimulationselektroden erzeugt werden können.
- System zur Planung der Implantation einer Neurostimulationssonde nach Anspruch 1, ferner mit einer Benutzerschnittstelle, um es einem Benutzer zu ermöglichen, die Zielregion und/oder das wenigstens eine Faserbündel mit einer hohen Stimulationsvorzugswürdigkeit und/oder das wenigstens eine Faserbündel mit einer geringen Stimulationsvorzugswürdigkeit auszuwählen.
- System zur Planung der Implantation einer Neurostimulationssonde nach Anspruch 1, bei dem der Ausgang eine Anzeige zum Anzeigen einer graphischen Darstellung der Zielregion und der optimalen Position und Ausrichtung zur Implantation der Neurostimulationssonde umfasst.
- System zur Planung der Implantation einer Neurostimulationssonde nach Anspruch 1, ferner mit einer bildgebenden Magnetresonanzvorrichtung zur Gewinnung der anatomischen Daten.
- Verfahren zur Planung der Implantation einer Neurostimulationssonde, wobei das Verfahren die folgenden Schritte umfasst:- Empfangen anatomischer Daten, die Informationen bezüglich einer Position und einer Ausrichtung wenigstens eines Faserbündels in einer Zielregion umfassen,- Empfangen therapeutischer Informationen, die Informationen bezüglich einer Stimulationsvorzugswürdigkeit des wenigstens einen Faserbündels umfassen,- Berechnen wenigstens einer optimalen Position und wenigstens einer optimalen Ausrichtung zur Implantation der Neurostimulationssonde anhand der Position, der Ausrichtung und der Stimulationsvorzugswürdigkeit, wobei die Sonde in der optimalen Position und mit der optimalen Ausrichtung zur Erzeugung eines Gradienten eines elektrischen Feldes in der Lage ist, der im Wesentlichen parallel zu wenigstens einem Faserbündel mit einer hohen Stimulationsvorzugswürdigkeit und/oder im Wesentlichen senkrecht zu wenigstens einem Faserbündel mit einer geringen Stimulationsvorzugswürdigkeit ist, und- Liefern der optimalen Position und Ausrichtung.
- Computerlesbarer Datenträger, der ein Computerprogramm zur Planung der Implantation einer Neurostimulationssonde trägt, wobei das Programm so betrieben wird, dass es bei Ausführung auf einem Prozessor den Prozessor dazu veranlasst, das Verfahren nach Anspruch 6 durchzuführen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11776793.9A EP2632546B1 (de) | 2010-10-29 | 2011-10-31 | Planungssystem für eine nervenstimulationstherapie |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10189497 | 2010-10-29 | ||
EP11776793.9A EP2632546B1 (de) | 2010-10-29 | 2011-10-31 | Planungssystem für eine nervenstimulationstherapie |
PCT/EP2011/069104 WO2012056040A1 (en) | 2010-10-29 | 2011-10-31 | Planning system for neurostimulation therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2632546A1 EP2632546A1 (de) | 2013-09-04 |
EP2632546B1 true EP2632546B1 (de) | 2014-09-10 |
Family
ID=44903237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11776793.9A Active EP2632546B1 (de) | 2010-10-29 | 2011-10-31 | Planungssystem für eine nervenstimulationstherapie |
Country Status (6)
Country | Link |
---|---|
US (1) | US8498709B2 (de) |
EP (1) | EP2632546B1 (de) |
KR (1) | KR20130122940A (de) |
CN (1) | CN103167893A (de) |
RU (1) | RU2013124819A (de) |
WO (1) | WO2012056040A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009276603B2 (en) | 2008-07-30 | 2015-11-12 | Ecole Polytechinique Federale De Lausanne (Epfl) | Apparatus and method for optimized stimulation of a neurological target |
US8788064B2 (en) | 2008-11-12 | 2014-07-22 | Ecole Polytechnique Federale De Lausanne | Microfabricated neurostimulation device |
WO2011067297A1 (en) | 2009-12-01 | 2011-06-09 | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE | Microfabricated neurostimulation device and methods of making and using the same |
US9549708B2 (en) | 2010-04-01 | 2017-01-24 | Ecole Polytechnique Federale De Lausanne | Device for interacting with neurological tissue and methods of making and using the same |
US20140067354A1 (en) * | 2012-08-31 | 2014-03-06 | Greatbatch Ltd. | Method and System of Suggesting Spinal Cord Stimulation Region Based on Pain and Stimulation Maps with a Clinician Programmer |
CN110585588A (zh) | 2014-05-16 | 2019-12-20 | 阿莱瓦神经治疗股份有限公司 | 可植入式微电极装置 |
US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
US9925376B2 (en) | 2014-08-27 | 2018-03-27 | Aleva Neurotherapeutics | Treatment of autoimmune diseases with deep brain stimulation |
US9403011B2 (en) | 2014-08-27 | 2016-08-02 | Aleva Neurotherapeutics | Leadless neurostimulator |
US9474894B2 (en) | 2014-08-27 | 2016-10-25 | Aleva Neurotherapeutics | Deep brain stimulation lead |
FR3025629B1 (fr) * | 2014-09-04 | 2022-12-16 | Univ Rennes | Procede de simulation de stimulation cerebrale, dispositif et programme d'ordinateur correspondant |
CN107110944B (zh) * | 2014-10-17 | 2019-11-22 | 圣纳普医疗(巴巴多斯)公司 | 连接性制图之系统及方法 |
US10702692B2 (en) | 2018-03-02 | 2020-07-07 | Aleva Neurotherapeutics | Neurostimulation device |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6353762B1 (en) | 1999-04-30 | 2002-03-05 | Medtronic, Inc. | Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve |
WO2004096018A2 (en) | 2003-04-28 | 2004-11-11 | Vanderbilt University | Apparatus and methods of optimal placement of deep brain stimulator |
WO2006034305A2 (en) | 2004-09-21 | 2006-03-30 | University Of Florida Research Foundation, Inc. | Multiple lead method for deep brain stimulation |
US8401650B2 (en) * | 2008-04-10 | 2013-03-19 | Electrocore Llc | Methods and apparatus for electrical treatment using balloon and electrode |
WO2008018067A2 (en) | 2006-08-07 | 2008-02-14 | Alpha Omega Engineering Ltd. | Cerebral electrodes and methods of operating same |
RU2463088C2 (ru) | 2006-09-26 | 2012-10-10 | Сапиенс Стиринг Брейн Стимулейшн Б.В. | Способ и устройство для стимуляции тканей |
WO2009139917A2 (en) * | 2008-05-15 | 2009-11-19 | Intelect Medical, Inc. | Clinician programmer clinician programmer system and method for generating interface models and displays of volumes of activation |
EP3520855B1 (de) * | 2009-04-16 | 2024-05-29 | Boston Scientific Neuromodulation Corporation | Tiefenhirnstimulationsstromlenkung mit geteilten elektroden |
-
2011
- 2011-10-31 EP EP11776793.9A patent/EP2632546B1/de active Active
- 2011-10-31 CN CN2011800518462A patent/CN103167893A/zh active Pending
- 2011-10-31 WO PCT/EP2011/069104 patent/WO2012056040A1/en active Application Filing
- 2011-10-31 US US13/285,136 patent/US8498709B2/en active Active
- 2011-10-31 RU RU2013124819/14A patent/RU2013124819A/ru not_active Application Discontinuation
- 2011-10-31 KR KR1020137009602A patent/KR20130122940A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2632546A1 (de) | 2013-09-04 |
KR20130122940A (ko) | 2013-11-11 |
CN103167893A (zh) | 2013-06-19 |
WO2012056040A1 (en) | 2012-05-03 |
US8498709B2 (en) | 2013-07-30 |
RU2013124819A (ru) | 2014-12-10 |
US20120109599A1 (en) | 2012-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2632546B1 (de) | Planungssystem für eine nervenstimulationstherapie | |
EP2632537B1 (de) | Neurostimulationsvorrichtung mit mehreren elektroden | |
US10806929B2 (en) | Systems and method for deep brain stimulation therapy | |
EP2533851B1 (de) | System zur definition der einstellungen für tiefe hirnstimulation | |
EP2697780B1 (de) | Implantierbare medizinische vorrichtungen mit speicherung von grafikverarbeitungsdaten | |
EP2790776B1 (de) | Programmierschnittstelle zur rückenmarks-neuromodulation | |
US9867989B2 (en) | Programming interface for spinal cord neuromodulation | |
EP2419171B1 (de) | Modelle für neurokranielle elektrostimulation | |
US20160144194A1 (en) | Determining effective electrodes for electrical stimulation | |
US20070203545A1 (en) | User interface with 3D environment for configuring stimulation therapy | |
WO2012054612A1 (en) | Methods for identifying target stimulation regions associated with therapeutic and non-therapeutic clinical outcomes for neural stimulation | |
CN110944710A (zh) | 估计电刺激的临床效果的系统和方法 | |
US20190015660A1 (en) | Systems and methods for planning and programming electrical stimulation | |
Zhang | Programming and Sensing with Deep Brain Stimulation Arrays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130517 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140326 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 686346 Country of ref document: AT Kind code of ref document: T Effective date: 20141015 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011009846 Country of ref document: DE Effective date: 20141023 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141211 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141210 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602011009846 Country of ref document: DE Representative=s name: DTS PATENT- UND RECHTSANWAELTE SCHNEKENBUEHL U, DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140910 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 686346 Country of ref document: AT Kind code of ref document: T Effective date: 20140910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150110 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150112 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602011009846 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141031 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141031 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141031 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20150630 |
|
26N | No opposition filed |
Effective date: 20150611 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141112 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20151031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151031 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20111031 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140910 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230920 Year of fee payment: 13 |